Market expert Rakesh Arora says Sun Pharma's Halol facility may come up for inspection by the US drug regulator in the near term, which could be one of the big triggers for the sector. Pharma stocks have seen significant correction from their peaks and investors may look at increasing their bets in this space, he adds.